LiveMint-Keywords


Teva’s patents for cardiac drug are invalid: Glenmark C.H. Unnikrishnan 10:59 PM \| December 04,2008 Teva believes that its patents are valid and Glenmark infringes those patents FIND MORE ARTICLES ON: Cardiac drug Teva Glenmark Pharmaceutical Industries Dr Reddy Laboratories
NTK \| NMDC eyes Rs35,000 cr revenue by 2015 C.R. Sukumar 01:06 AM \| August 30,2008 The firm’s capital expenditure plans include a greenfield steel project in Chhattisgarh worth Rs14,000 crore and a pig iron plant at Rs1,400 crore FIND MORE ARTICLES ON: NMDC SpiceJet Gammon Infrastructure Hindalco SBI ICICI Bank Teva Novartis